76282-256 : Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated
NDC: | 76282-256 |
Labeler: | Exelan Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Raloxifene Hydrochloride |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | ANDA090842 |
Rev. Date: |
Appearance:
Markings: | IG;256 |
Shapes: |
Round |
Colors: |
White |
Size (mm): | 9 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 76282-256-01: 100 TABLET, FILM COATED IN 1 BOTTLE (76282‑256‑01)
- 76282-256-05: 500 TABLET, FILM COATED IN 1 BOTTLE (76282‑256‑05)
- 76282-256-10: 1000 TABLET, FILM COATED IN 1 BOTTLE (76282‑256‑10)
- 76282-256-30: 30 TABLET, FILM COATED IN 1 BOTTLE (76282‑256‑30)
- 76282-256-90: 90 TABLET, FILM COATED IN 1 BOTTLE (76282‑256‑90)
Active Ingredients:
- Raloxifene Hydrochloride
Dosage Strength:
- 60 mg
Inactive Ingredients:
- Mannitol
- Crospovidone
- Hydroxypropyl Cellulose
- Poloxamer 407
- Magnesium Stearate
- Titanium Dioxide
- Hypromellose 2910 (3 Mpa.s)
- Hypromellose 2910 (6 Mpa.s)
- Polyethylene Glycol 400
- Polysorbate 80
Pharmaceutical Classes:
- Estrogen Agonist/Antagonist [EPC]
- Selective Estrogen Receptor Modulators [MoA]
Related Products:
Based on records with the same trade name.- 0093-7290 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA Inc
- 0179-0151 Raloxifene Hydrochloride 60 mg Oral Tablet by Kaiser Foundation Hospitals
- 0179-0212 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Kaiser Foundation Hospitals
- 0179-0220 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Kaiser Foundation Hospitals
- 0440-5295 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Liberty Pharmaceuticals, Inc.
- 0904-6902 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Major Pharmaceuticals
- 16714-213 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Northstar Rx LLC
- 31722-256 Raloxifene Hydrochloride 60 mg Oral Tablet by Camber Pharmaceuticals Inc
- 42291-726 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Avkare, Inc.
- 43353-253 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Aphena Pharma Solutions - Tennessee, LLC
- 43598-505 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Dr.reddy’s Laboratories Inc
- 50090-3363 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by A-s Medication Solutions
- 50090-3866 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by A-s Medication Solutions
- 50090-5458 Raloxifene Hydrochloride 60 mg Oral Tablet by A-s Medication Solutions
- 50090-6177 Raloxifene Hydrochloride 60 mg Oral Tablet, Coated by A-s Medication Solutions
- 50090-7073 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by A-s Medication Solutions
- 50228-306 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Sciegen Pharmaceuticals Inc
- 50268-694 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Avpak
- 52343-137 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Lucid Pharma LLC
- 60687-266 Raloxifene Hydrochloride 60 mg Oral Tablet by American Health Packaging
- More related products ...
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 76282-251Next: 76282-257 >
Related Discussions:
raloxifene HCL evista lilly sa
prevention osteoporosis ## medical prescriptio for preventio of osteoporosis post menopausia... 1 reply
prevention osteoporosis ## medical prescriptio for preventio of osteoporosis post menopausia... 1 reply
raloxifene HCL
evista Lilly SA...
evista Lilly SA...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.